AVE 0.00% 0.3¢ avecho biotechnology limited

esra oxypatch 4 years., page-49

  1. 12,402 Posts.
    lightbulb Created with Sketch. 1110
    Hi meagain


    In my opinion POH have no approval whats so ever to do any trials phase2 or Phase 3,

    They are yet to even submit an IND.

    They have advice that they might be able to go straight to phase 3 via a 505(B)(a) ruling.

    I dont believe at this stage they have been notified that thats the case.

    If so it should read We have been notified by the FDA, like every other Biotech announcement.

    Regards,



 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
21 34259955 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 40753304 27
View Market Depth
Last trade - 16.12pm 07/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.